A. J. Kazimi
Chairman and CEO at Cumberland Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cumberland Pharmaceuticals Inc., 3 years.
Cumberland Pharmaceuticals Inc.
Director · Chairman and CEO
Chief executive roles
Cumberland Pharmaceuticals Inc.
· Chairman and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Cumberland Pharmaceuticals Inc. | Shares withheld for tax | −5,845 | $3.06 | $17,886 |
| Dec 31, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +7 | $3.91 | $27 |
| Dec 30, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +8 | $3.94 | $32 |
| Dec 29, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +8 | $4.01 | $32 |
| Dec 26, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +8 | $4.21 | $34 |
| Dec 24, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +8 | $4.26 | $34 |
| Dec 23, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +8 | $4.13 | $33 |
| Dec 22, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +7 | $4.32 | $30 |
| Dec 19, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +8 | $4.19 | $34 |
| Dec 18, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +10 | $4.19 | $42 |
| Dec 17, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +10 | $3.65 | $37 |
| Dec 16, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +14 | $3.27 | $46 |
| Dec 15, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +14 | $2.82 | $39 |
| Dec 12, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +14 | $2.50 | $35 |
| Dec 11, 2025 | Cumberland Pharmaceuticals Inc. | Small acquisition | +14 | $2.56 | $36 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.